Specifically, as shown in Fig. 7k, higher CCL5 levels in the VNP@Sgc8c-MMAE group indicate its role in recruiting T cells to the tumor site, thereby enhancing the immune response and creating a more favorable environment for immunotherapy. Here, CCL5 is linked to neoplasm.